USP General Chapter <825> Impact on Nuclear Medicine Technology Practice.
USP <825>
USP standards
radiopharmaceutical compounding
sterile radiopharmaceutical
Journal
Journal of nuclear medicine technology
ISSN: 1535-5675
Titre abrégé: J Nucl Med Technol
Pays: United States
ID NLM: 0430303
Informations de publication
Date de publication:
Jun 2020
Jun 2020
Historique:
received:
25
02
2020
accepted:
22
04
2020
entrez:
6
6
2020
pubmed:
6
6
2020
medline:
9
2
2021
Statut:
ppublish
Résumé
U.S. Pharmacopeia (USP) general chapter <825>, "Radiopharmaceuticals: Preparation, Compounding, Dispensing, and Repackaging," is a new standard proposed to provide minimum requirements for the preparation, compounding, dispensing, and repackaging of sterile and nonsterile radiopharmaceuticals. This new standard represents endeavors on the part of the USP to respond to appeals by nuclear medicine professionals to move beyond a minimal supplement to USP <797> and provide policies specific to radiopharmaceuticals. USP <825> provides nuclear pharmacies and nuclear medicine departments in hospitals and clinics with the benchmarks to assess current practice activities and integrate needed changes to meet regulatory and accreditation audit reviews. This continuing education article focuses on components of USP <825> specific to the nuclear medicine technologist for a better understanding of obligations when preparing sterile radiopharmaceuticals for clinical use.
Identifiants
pubmed: 32499321
pii: 48/2/106
doi: 10.2967/jnmt.120.243378
doi:
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
106-113Informations de copyright
© 2020 by the Society of Nuclear Medicine and Molecular Imaging.